Treatment response of cystic echinococcosis to benzimidazoles: a systematic review.
Over the past 30 years, benzimidazoles have increasingly been used to treat cystic echinococcosis (CE). The efficacy of benzimidazoles, however, remains unclear. We systematically searched MEDLINE, EMBASE, SIGLE, and CCTR to identify studies on benzimidazole treatment outcome. A large heterogeneity...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1f8f5f9875a4bf687005f952e07ccf3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:d1f8f5f9875a4bf687005f952e07ccf3 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:d1f8f5f9875a4bf687005f952e07ccf32021-12-02T20:23:52ZTreatment response of cystic echinococcosis to benzimidazoles: a systematic review.1935-27271935-273510.1371/journal.pntd.0000524https://doaj.org/article/d1f8f5f9875a4bf687005f952e07ccf32009-09-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19787039/?tool=EBIhttps://doaj.org/toc/1935-2727https://doaj.org/toc/1935-2735Over the past 30 years, benzimidazoles have increasingly been used to treat cystic echinococcosis (CE). The efficacy of benzimidazoles, however, remains unclear. We systematically searched MEDLINE, EMBASE, SIGLE, and CCTR to identify studies on benzimidazole treatment outcome. A large heterogeneity of methods in 23 reports precluded a meta-analysis of published results. Specialist centres were contacted to provide individual patient data. We conducted survival analyses for cyst response defined as inactive (CE4 or CE5 by the ultrasound-based World Health Organisation [WHO] classification scheme) or as disappeared. We collected data from 711 treated patients with 1,308 cysts from six centres (five countries). Analysis was restricted to 1,159 liver and peritoneal cysts. Overall, 1-2 y after initiation of benzimidazole treatment 50%-75% of active C1 cysts were classified as inactive/disappeared compared to 30%-55% of CE2 and CE3 cysts. Further in analyzing the rate of inactivation/disappearance with regard to cyst size, 50%-60% of cysts <6 cm responded to treatment after 1-2 y compared to 25%-50% of cysts >6 cm. However, 25% of cysts reverted to active status within 1.5 to 2 y after having initially responded and multiple relapses were observed; after the second and third treatment 60% of cysts relapsed within 2 y. We estimated that 2 y after treatment initiation 40% of cysts are still active or become active again. The overall efficacy of benzimidazoles has been overstated in the past. There is an urgent need for a pragmatic randomised controlled trial that compares standardized benzimidazole therapy on responsive cyst stages with the other treatment modalities.Marija StojkovicMarcel ZwahlenAntonella TeggiKamenna VutovaCarmen M CretuRoberto VirdonePolyxeni NicolaidouNazan CobanogluThomas JunghanssPublic Library of Science (PLoS)articleArctic medicine. Tropical medicineRC955-962Public aspects of medicineRA1-1270ENPLoS Neglected Tropical Diseases, Vol 3, Iss 9, p e524 (2009) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 |
spellingShingle |
Arctic medicine. Tropical medicine RC955-962 Public aspects of medicine RA1-1270 Marija Stojkovic Marcel Zwahlen Antonella Teggi Kamenna Vutova Carmen M Cretu Roberto Virdone Polyxeni Nicolaidou Nazan Cobanoglu Thomas Junghanss Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
description |
Over the past 30 years, benzimidazoles have increasingly been used to treat cystic echinococcosis (CE). The efficacy of benzimidazoles, however, remains unclear. We systematically searched MEDLINE, EMBASE, SIGLE, and CCTR to identify studies on benzimidazole treatment outcome. A large heterogeneity of methods in 23 reports precluded a meta-analysis of published results. Specialist centres were contacted to provide individual patient data. We conducted survival analyses for cyst response defined as inactive (CE4 or CE5 by the ultrasound-based World Health Organisation [WHO] classification scheme) or as disappeared. We collected data from 711 treated patients with 1,308 cysts from six centres (five countries). Analysis was restricted to 1,159 liver and peritoneal cysts. Overall, 1-2 y after initiation of benzimidazole treatment 50%-75% of active C1 cysts were classified as inactive/disappeared compared to 30%-55% of CE2 and CE3 cysts. Further in analyzing the rate of inactivation/disappearance with regard to cyst size, 50%-60% of cysts <6 cm responded to treatment after 1-2 y compared to 25%-50% of cysts >6 cm. However, 25% of cysts reverted to active status within 1.5 to 2 y after having initially responded and multiple relapses were observed; after the second and third treatment 60% of cysts relapsed within 2 y. We estimated that 2 y after treatment initiation 40% of cysts are still active or become active again. The overall efficacy of benzimidazoles has been overstated in the past. There is an urgent need for a pragmatic randomised controlled trial that compares standardized benzimidazole therapy on responsive cyst stages with the other treatment modalities. |
format |
article |
author |
Marija Stojkovic Marcel Zwahlen Antonella Teggi Kamenna Vutova Carmen M Cretu Roberto Virdone Polyxeni Nicolaidou Nazan Cobanoglu Thomas Junghanss |
author_facet |
Marija Stojkovic Marcel Zwahlen Antonella Teggi Kamenna Vutova Carmen M Cretu Roberto Virdone Polyxeni Nicolaidou Nazan Cobanoglu Thomas Junghanss |
author_sort |
Marija Stojkovic |
title |
Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
title_short |
Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
title_full |
Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
title_fullStr |
Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
title_full_unstemmed |
Treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
title_sort |
treatment response of cystic echinococcosis to benzimidazoles: a systematic review. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2009 |
url |
https://doaj.org/article/d1f8f5f9875a4bf687005f952e07ccf3 |
work_keys_str_mv |
AT marijastojkovic treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT marcelzwahlen treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT antonellateggi treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT kamennavutova treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT carmenmcretu treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT robertovirdone treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT polyxeninicolaidou treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT nazancobanoglu treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview AT thomasjunghanss treatmentresponseofcysticechinococcosistobenzimidazolesasystematicreview |
_version_ |
1718374135058399232 |